Generation of induced pluripotent stem cell line ISMMSi060-A from a patient with combined oxidative phosphorylation deficiency 25

Summary

We have described a novel mitochondrial disorder caused by biallelic pathogenic variants in the methionyl-tRNA synthetase 2 gene (MARS2), now termed Combined oxidative phosphorylation deficiency 25 (COXPD25). This study focuses on the generation and characterization of induced pluripotent stem cells (iPSCs) from fibroblasts of a patient with COXPD25. The resulting iPSC line ISMMSi060-A, carries the compound heterozygous variants c.550C > T; p.Gln184* and c.424C > T; p.Arg142Trp in MARS2. The iPSCs exhibited normal cell morphology, expression of pluripotency markers, genome integrity, and the ability to differentiate. Copyright © 2025 The Authors. Published by Elsevier B.V. All rights reserved.

Authors Salemi SE, Baljinnyam E, Liu NN, Hu R, Marro SG, Webb BD
Journal Stem cell research
Publication Date 2025 Mar;83:103662
PubMed 39874649
DOI 10.1016/j.scr.2025.103662

Research Projects

Cell Lines

  • (none)